As of 2026-09-18, the Intrinsic Value of Spruce Biosciences Inc (SPRB) is -67.62 USD. This SPRB valuation is based on the model Peter Lynch Fair Value. With the current market price of 53.86 USD, the upside of Spruce Biosciences Inc is -225.55%.
Based on its market price of 53.86 USD and our intrinsic valuation, Spruce Biosciences Inc (SPRB) is overvalued by 225.55%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -67.62 - -67.62 | -67.62 | -225.55% |
| P/E | (258.31) - (316.46) | (276.57) | -613.5% |
| DDM - Stable | (91.54) - (257.33) | (174.44) | -423.9% |
| DDM - Multi | (65.68) - (147.05) | (91.18) | -269.3% |
| Market Cap (mil) | 148.12 |
| Beta | -35.59 |
| Outstanding shares (mil) | 2.75 |
| Enterprise Value (mil) | 58.91 |
| Market risk premium | 4.60% |
| Cost of Equity | 11.54% |
| Cost of Debt | 5.00% |
| WACC | 7.60% |